FindMyKOL

Erika Lease, MD

Basic profile

University of Washington

ORCIDOn fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionSeattle, WA · WestSpecialtyPulmonary DiseaseFocusRespiratory
Active KOLFindMyKOL type: NationalLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Erika Lease is a Respiratory physician affiliated with University of Washington. OpenAlex indexes 119 publications with 3,842 citations (h-index 26).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
119publications

Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.

3,842citations

Citations across these publications.

26h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
5companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Industry payments

5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • KAMADA LTD.
    Program year20251 payment
    $5,100
  • La Jolla Pharmaceutical Company
    Program year20251 payment
    $92
  • Zambon USA Ltd.
    Program year20247 payments
    $6,669
All 5 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    37.4%
    Short-acting sulfonamides17.7%
    Sulfamethoxazole-Trimethoprim100%
    Part D≥122 patients
    Macrolide Antimicrobial8.4%
    Azithromycin100%
    Part D≥62 patients

    + 5 more classes in this area

  • Metabolism & gastrointestinal

    27.2%
    Proton pump inhibitor12.1%
    Pantoprazole Sodium58%Omeprazole42%
    Part D≥43 patients
    Corticosteroid11.5%
    Prednisone100%
    Part D≥92 patients

    + 6 more classes in this area

  • Cardiovascular

    15.4%
    Statin12.8%
    Atorvastatin Calcium54%Pravastatin Sodium38%Rosuvastatin Calcium8%
    Part D<11 patients
    Loop diuretic2.1%
    Furosemide66%Bumetanide35%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”